Compassionate use of tetrabenazine for the treatment of levodopa induced dyskinesias in patients with Parkinson's disease who are either resistant or intolerant to amantadine

Trial Profile

Compassionate use of tetrabenazine for the treatment of levodopa induced dyskinesias in patients with Parkinson's disease who are either resistant or intolerant to amantadine

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 17 Dec 2015

At a glance

  • Drugs Tetrabenazine (Primary)
  • Indications Drug-induced dyskinesia
  • Focus Expanded access; Therapeutic Use
  • Most Recent Events

    • 17 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top